ASH 2018 | Flow cytometry vs. NGS testing for determining MRD negativity in patients with ALL

Name: Flow cytometry vs. NGS testing for determining MRD negativity in patients with ALL
Uploaded: 2018-12-01T00:00:00.000Z
Duration: 1 min 28 s
Description: Stephan Grupp, MD, PhD, of the Children’s Hospital of Philadelphia, Philadelphia, PA, speaking from the American Society of Hematology (ASH) 2018 Annual Meeting and Exposition in San Diego, CA, discusses the use of flow cytometry and NGS testing for determining MRD negativity in patients with acute lymphoblastic leukemia (ALL).

Stephan Grupp • 1 Dec 2018

ASH 2018

Acute Lymphoblastic Leukemia Leukemia

Stephan Grupp, MD, PhD, of the Children’s Hospital of Philadelphia, Philadelphia, PA, speaking from the American Society of Hematology (ASH) 2018 Annual Meeting and Exposition in San Diego, CA, discusses the use of flow cytometry and NGS testing for determining MRD negativity in patients with acute lymphoblastic leukemia (ALL).